Hans Jansen

2.7k citations

60 papers · 2.0k indexed · h-index 27

Impact in

Endocrinology, Diabetes and Metabolism top 1%
- Diabetes, Cardiovascular Risks, and Lipoproteins
Cardiology and Cardiovascular Medicine top 2%
- Lipid metabolism and disorders

Papers in

Endocrinology, Diabetes and Metabolism 38
- Diabetes, Cardiovascular Risks, and Lipoproteins 28
Biochemistry 9
- Lipid metabolism and biosynthesis 9

Co-authors: D.W. Erkelens M. Castro Cabezas T W de Bruin J.C. Birkenhäger L A Kock Geesje M. Dallinga‐Thie Carol C. Shoulders Harold W. de Valk
Journals: Metabolism (6 papers)Atherosclerosis (6 papers)Journal of Lipid Research (6 papers)Arteriosclerosis Thrombosis and Vascular Biology (5 papers)Diabetes Care (3 papers)
Partner nations: Netherlands United States Germany

In The Last Decade

Hans Jansen

59 papers receiving 1.9k citations

Peers

Countries citing papers authored by Hans Jansen

Since Specialization

Citations

This map shows the geographic impact of Hans Jansen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans Jansen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans Jansen more than expected).

Fields of papers citing papers by Hans Jansen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hans Jansen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans Jansen. The network helps show where Hans Jansen may publish in the future.

Co-authors

The 25 scholars most cited alongside Hans Jansen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Hans Jansen Line = papers co-authored together Hans Jansen links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	ANGPTL3 Inhibition With Evinacumab Results in Faster Clearance of IDL and LDL apoB in Patients With Homozygous Familial Hypercholesterolemia—Brief Report Arteriosclerosis Thrombosis and Vascular Biology ·Laurens F. Reeskamp, John S. Millar, WU Li-ya, Hans Jansen, Dewi van Harskamp, Henk Schierbeek, Daniel A. Gipe, Daniel J. Rader, Geesje M. Dallinga‐Thie, G. Kees Hovingh, Marina Cuchel	2021	67
2	Taking One Step Back in Familial Hypercholesterolemia Arteriosclerosis Thrombosis and Vascular Biology ·Natalia Loaiza, Merel L. Hartgers, Laurens F. Reeskamp, Jan-Willem Balder, Antoine Rimbert, Venetia Bazioti, Justina C. Wolters, Maaike Winkelmeijer, Hans Jansen, Geesje M. Dallinga‐Thie, Andrea Volta, Nicolette Huijkman, Marieke Smit, Niels Kloosterhuis, Mirjam H. Koster, Arthur Flohr Svendsen, Bart van de Sluis, G. Kees Hovingh, Aldo Grefhorst, Jan Albert Kuivenhoven	2020	32
3	Appraisal of hepatic lipase and lipoprotein lipase activities in mice Journal of Lipid Research ·Geesje M. Dallinga‐Thie, A.J. Zonneveld-de Boer, Leonie C. van Vark‐van der Zee, Rien van Haperen, Teus van Gent, Hans Jansen, Rini de Crom, Arie van Tol	2007	24
4	Cloning, expression, and promoter analysis of hepatic lipase derived from human hyperplastic adrenals Cell Biochemistry and Biophysics ·Gert-Jan Botma, Mirjam Heuveling, Jos M. J. Lamers, Hans Jansen, Adrie J.M. Verhoeven	2007	2
5	Common variants of multiple genes that control reverse cholesterol transport together explain only a minor part of the variation of HDL cholesterol levels Clinical Genetics ·S. Matthijs Boekholdt, OW Souverein, Michael W.T. Tanck, GK Hovingh, JA Kuivenhoven, RIG Peters, Hans Jansen, PMH Schiffers, EE van der Wall, PA Doevendans, PH Reitsma, A. H. Zwinderman, JJP Kastelein, J. Wouter Jukema	2006	37
6	Hepatic lipase: Friend or foe and under what circumstances? Current Atherosclerosis Reports ·Hans Jansen	2004	18
7	Sterol-regulatory-element binding protein inhibits upstream stimulatory factor-stimulated hepatic lipase gene expression Atherosclerosis ·Gert-Jan Botma, Diederik van Deursen, Delfina Vieira, Mandy van Hoek, Hans Jansen, Adrie J.M. Verhoeven	2004	21
8	Effects of atorvastatin on fasting and postprandial complement component 3 response in familial combined hyperlipidemia Journal of Lipid Research ·C. Verseyden, S. Meijssen, Johannes van Dijk, Hans Jansen, M. Castro Cabezas	2003	29
9	Testosterone up-regulates scavenger receptor BI and stimulates cholesterol efflux from macrophages Biochemical and Biophysical Research Communications ·Claus Langer, Barbara Gansz, Christian Goepfert, Thomas Engel, Yoshinari Uehara, Gerlinde von Dehn, Hans Jansen, Gerd Assmann, Arnold von Eckardstein	2002	127
10	Induction of Adrenal Scavenger Receptor BI and Increased High Density Lipoprotein-Cholesteryl Ether Uptake by in Vivo Inhibition of Hepatic Lipase Journal of Biological Chemistry ·Delfina Vieira-van Bruggen, Ina Kalkman, Teus van Gent, Arie van Tol, Hans Jansen	1998	32
11	Conversion from cyclosporine A to azathioprine treatment improves LDL oxidation in kidney transplant recipients Kidney International ·Marinus A. van den Dorpel, Hosam Ghanem, J. Rischen-Vos, A. J. Man inʼt Veld, Hans Jansen, Willem Weimar	1997	45
12	Low-density lipoprotein oxidation is increased in kidney transplant recipients Transplant International ·Marinus A. van den Dorpel, Hosam Ghanem, J. Rischen-Vos, A J Man in 't Veld, Hans Jansen, Willem Weimar	1996	1
13	Increased low density lipoprotein oxidation in stable kidney transplant recipients Kidney International ·Hosam Ghanem, Marinus A. van den Dorpel, Willem Weimar, A. J. Man inʼt Veld, Mohammed H. El-Kannishy, Hans Jansen	1996	68
14	Impaired fatty acid metabolism in familial combined hyperlipidemia. A mechanism associating hepatic apolipoprotein B overproduction and insulin resistance. Journal of Clinical Investigation ·M. Castro Cabezas, T W de Bruin, Harold W. de Valk, Carol C. Shoulders, Hans Jansen, D.W. Erkelens	1993	173
15	Different clearance of intravenously administered olive oil and soybean-oil emulsions: role of hepatic lipase American Journal of Clinical Nutrition ·CB Brouwer, Tjerk W.A. de Bruin, Hans Jansen, D.W. Erkelens	1993	40
16	Impaired chylomicron remnant clearance in familial combined hyperlipidemia. Arteriosclerosis and Thrombosis A Journal of Vascular Biology ·M. Castro Cabezas, T W de Bruin, Hans Jansen, L A Kock, Wouter Kortlandt, D.W. Erkelens	1993	116
17	Heparan sulphate proteoglycans are involved in the lipoprotein lipase-mediated enhancement of the cellular binding of very low density and low density lipoproteins Biochemical and Biophysical Research Communications ·Monique Mulder, Paola Lombardi, Hans Jansen, Theo J.C. van Berkel, Rune R. Frants, Louis M. Havekes	1992	106
18	Opposite regulation of hepatic lipase and lecithin: cholesterol acyltransferase by glucocorticoids in rats Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism ·Hans Jansen, Arie van Tol, Johan Auwerx, Grethe Skretting, Bart Staels	1992	32
19	Growth hormone and thyroxine affect lipoprotein metabolism in hypothyroid and hypophysectomized rats Journal of Endocrinology ·Nicoline Hoogerbrugge, Hans Jansen, Nicole M.H. Wouters, J.C. Birkenhäger	1990	8
20	Inhibition of hepatic cholesterol synthesis by the alpha1-adrenoceptor blocker doxazosin in the hypercholesterolemic golden hamster Life Sciences ·Hans Jansen, R. Lammers, M.G.A. Baggen, J.M.A Penders, J.C. Birkenhäger	1989	4

About Hans Jansen

Hans Jansen is a scholar working on Endocrinology, Diabetes and Metabolism, Biochemistry, Cardiology and Cardiovascular Medicine, Surgery and Biochemistry, having authored 60 papers that have together received 2.0k indexed citations. Recurring topics across this work include Diabetes, Cardiovascular Risks, and Lipoproteins (28 papers), Lipid metabolism and disorders (23 papers), Lipoproteins and Cardiovascular Health (20 papers), Lipid metabolism and biosynthesis (9 papers), Metabolism, Diabetes, and Cancer (6 papers), Liver Disease Diagnosis and Treatment (6 papers), Atherosclerosis and Cardiovascular Diseases (6 papers) and Cholesterol and Lipid Metabolism (6 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.1k citations), Cardiology and Cardiovascular Medicine (707 citations), Biochemistry (161 citations), Transplantation (58 citations) and Cancer Research (299 citations). Hans Jansen has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include D.W. Erkelens, M. Castro Cabezas, T W de Bruin, J.C. Birkenhäger, L A Kock, Geesje M. Dallinga‐Thie, Carol C. Shoulders, Harold W. de Valk, Wouter Kortlandt and Arie van Tol. Their work appears in journals such as Metabolism, Atherosclerosis, Journal of Lipid Research, Arteriosclerosis Thrombosis and Vascular Biology and Diabetes Care.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact